GRCE

Grace Therapeutics, Inc. GRCE

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 36 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$8.80M total
Cerity Partners LLC
$1.93M0.0%
Eversept Partners, LP
$1.75M+2.2%
BANK OF AMERICA CORP /DE/
$1.12M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$934.6K+2.5%
CITADEL ADVISORS LLC
$793.9K+254.2%
Maven Securities LTD
$454.0KNew
Birchview Capital, LP
$272.4K+140.0%
CANTOR FITZGERALD, L. P.
$227.0KNew
TWO SIGMA INVESTMENTS, LP
$219.9KNew
JANE STREET GROUP, LLC
$203.0K-46.5%
XTX Topco Ltd
$162.7K+13.6%
HRT FINANCIAL LP
$142.0KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$112.5KNew
BlackRock, Inc.
$85.2KNew
Stonepine Capital Management, LLC
$62.1KNew
Rangeley Capital, LLC
$59.0KNew
KESTRA PRIVATE WEALTH SERVICES, LLC
$52.2K+76.9%
UBS Group AG
$38.1K-36.2%
Stratos Investment Management, LLC
$25.3KNew
BNP PARIBAS FINANCIAL MARKETS
$23.8K+47.9%
Scientech Research LLC
$23.1KNew
Virtu Financial LLC
$23.0KNew
OPPENHEIMER & CO INC
$22.7K0.0%
MORGAN STANLEY
$21.4K+107.7%
VANGUARD FIDUCIARY TRUST CO
$19.9K0.0%
See all 34 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/GRCE

Earnings Per Share

13fpro.ai/company/GRCE

Loading ratio trend…

GRCE key financials by period

Reported revenue, net income and operating margin by fiscal year, from Grace Therapeutics, Inc.'s annual filings on SEC EDGAR.

Grace Therapeutics, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2022$100.0M$-9.8M-15.6%
FY 2021$196.0K$-19.7M—
Source: GRCE filings on SEC EDGAR →

GRCE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Grace Therapeutics, Inc. (GRCE): stock profile, AI score and financials

Grace Therapeutics, Inc. (GRCE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GRCE is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 36 institutional filers currently hold this stock. Top institutional holders of GRCE by reported 13-F value include Cerity Partners, Eversept Partners, BANK OF AMERICA, based on the most recent SEC filings. GRCE trades on the Nasdaq exchange and files with the SEC under CIK 1444192. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GRCE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Grace Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1444192 →